[go: up one dir, main page]

ES2174551T3 - Utilizacion de alcanos semifluorados como agentes dermatologicos. - Google Patents

Utilizacion de alcanos semifluorados como agentes dermatologicos.

Info

Publication number
ES2174551T3
ES2174551T3 ES99105854T ES99105854T ES2174551T3 ES 2174551 T3 ES2174551 T3 ES 2174551T3 ES 99105854 T ES99105854 T ES 99105854T ES 99105854 T ES99105854 T ES 99105854T ES 2174551 T3 ES2174551 T3 ES 2174551T3
Authority
ES
Spain
Prior art keywords
semifluorated
alkans
dermatological agents
dermatological
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99105854T
Other languages
English (en)
Inventor
Hasso Meinert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7773697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2174551(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2174551T3 publication Critical patent/ES2174551T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/23Preparation of halogenated hydrocarbons by dehalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/269Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions of only halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/272Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by addition reactions
    • C07C17/275Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by addition reactions of hydrocarbons and halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00Acyclic saturated compounds containing halogen atoms
    • C07C19/08Acyclic saturated compounds containing halogen atoms containing fluorine
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10LFUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIGHTERS
    • C10L1/00Liquid carbonaceous fuels
    • C10L1/10Liquid carbonaceous fuels containing additives
    • C10L1/14Organic compounds
    • C10L1/20Organic compounds containing halogen
    • C10L1/201Organic compounds containing halogen aliphatic bond
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10LFUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIGHTERS
    • C10L1/00Liquid carbonaceous fuels
    • C10L1/10Liquid carbonaceous fuels containing additives
    • C10L1/14Organic compounds
    • C10L1/20Organic compounds containing halogen
    • C10L1/206Organic compounds containing halogen macromolecular compounds
    • C10L1/207Organic compounds containing halogen macromolecular compounds containing halogen with or without hydrogen
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M105/00Lubricating compositions characterised by the base-material being a non-macromolecular organic compound
    • C10M105/50Lubricating compositions characterised by the base-material being a non-macromolecular organic compound containing halogen
    • C10M105/52Lubricating compositions characterised by the base-material being a non-macromolecular organic compound containing halogen containing carbon, hydrogen and halogen only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M107/00Lubricating compositions characterised by the base-material being a macromolecular compound
    • C10M107/38Lubricating compositions characterised by the base-material being a macromolecular compound containing halogen
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M131/00Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen
    • C10M131/02Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen containing carbon, hydrogen and halogen only
    • C10M131/04Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen containing carbon, hydrogen and halogen only aliphatic
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M147/00Lubricating compositions characterised by the additive being a macromolecular compound containing halogen
    • C10M147/02Monomer containing carbon, hydrogen and halogen only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2211/00Organic non-macromolecular compounds containing halogen as ingredients in lubricant compositions
    • C10M2211/02Organic non-macromolecular compounds containing halogen as ingredients in lubricant compositions containing carbon, hydrogen and halogen only
    • C10M2211/022Organic non-macromolecular compounds containing halogen as ingredients in lubricant compositions containing carbon, hydrogen and halogen only aliphatic
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2211/00Organic non-macromolecular compounds containing halogen as ingredients in lubricant compositions
    • C10M2211/06Perfluorinated compounds
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2213/00Organic macromolecular compounds containing halogen as ingredients in lubricant compositions
    • C10M2213/02Organic macromolecular compounds containing halogen as ingredients in lubricant compositions obtained from monomers containing carbon, hydrogen and halogen only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2213/00Organic macromolecular compounds containing halogen as ingredients in lubricant compositions
    • C10M2213/06Perfluoro polymers
    • C10M2213/062Polytetrafluoroethylene [PTFE]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ALCANOS SEMIFLUORADOS DE FORMULAS GENERALES EN DONDE R SUB,F ES UN GRUPO DE PERFLUOROALQUILO LINEAL O RAMIFICADO Y R SUB,H ES UN GRUPO ALQUILO (HIDROCARBURO) LINEAL O RAMIFICADO Y SATURADO, Y SU UTILIZACION PARA AGENTES DE TRATAMIENTO DERMATOLOGICO.
ES99105854T 1995-09-29 1996-08-09 Utilizacion de alcanos semifluorados como agentes dermatologicos. Expired - Lifetime ES2174551T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19536504A DE19536504C2 (de) 1995-09-29 1995-09-29 Verwendung fluorierter Alkane

Publications (1)

Publication Number Publication Date
ES2174551T3 true ES2174551T3 (es) 2002-11-01

Family

ID=7773697

Family Applications (3)

Application Number Title Priority Date Filing Date
ES96927711T Expired - Lifetime ES2144259T5 (es) 1995-09-29 1996-08-09 Alcanos semifluorados y su utilizacion.
ES99105854T Expired - Lifetime ES2174551T3 (es) 1995-09-29 1996-08-09 Utilizacion de alcanos semifluorados como agentes dermatologicos.
ES99111588T Expired - Lifetime ES2174554T3 (es) 1995-09-29 1996-08-09 Utilizacion de alcanos semifluorados para la produccion de medios de respiracion artificial.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES96927711T Expired - Lifetime ES2144259T5 (es) 1995-09-29 1996-08-09 Alcanos semifluorados y su utilizacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99111588T Expired - Lifetime ES2174554T3 (es) 1995-09-29 1996-08-09 Utilizacion de alcanos semifluorados para la produccion de medios de respiracion artificial.

Country Status (9)

Country Link
US (3) US6262126B1 (es)
EP (3) EP0965334B1 (es)
JP (3) JP2000511157A (es)
KR (3) KR100497874B1 (es)
AT (3) ATE188958T1 (es)
CA (3) CA2473393C (es)
DE (4) DE19536504C2 (es)
ES (3) ES2144259T5 (es)
WO (1) WO1997012852A1 (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719280C1 (de) 1997-05-07 1998-09-24 Pharm Pur Gmbh Fluorierte Alkane und ihre Verwendungen
DE19811683C2 (de) * 1998-03-18 2000-03-23 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
DE19861012A1 (de) 1998-03-18 1999-09-30 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
DE19926890C1 (de) 1999-06-12 2000-07-27 Pharm Pur Gmbh Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
DE19926889B4 (de) 1999-06-12 2005-06-16 Bausch & Lomb Inc. Verwendung eines Gels mit Polyaphronstruktur zur Herstellung eines Implantats
US7357937B2 (en) 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
JP2007505927A (ja) * 2003-09-19 2007-03-15 ドラッグテック コーポレイション 薬物送達システム
DE10358306B8 (de) * 2003-12-08 2005-03-03 Coty B.V. Kosmetisches und dermatologisches Sauerstoff-Trägersystem, Verfahren zu dessen Herstellung sowie seine Verwendung
AU2005249497A1 (en) * 2004-06-01 2005-12-15 Roderic Nigel Fraser Simpson Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
DE102005055811A1 (de) * 2005-11-23 2007-05-31 Novaliq Gmbh Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
BRPI0620908A2 (pt) * 2006-01-05 2011-11-29 Drugtech Corp composição farmacêutica, sistema de distribuição antibacteriana e antifúngica vaginal e uso da composição farmacêutica
DE102007055046A1 (de) * 2007-11-19 2009-05-28 Fluoron Gmbh Infusionslösung
WO2009111023A2 (en) * 2008-03-04 2009-09-11 Cornell University Triblock polymers and polymer coatings
PL2110126T3 (pl) * 2008-04-18 2012-04-30 Novaliq Gmbh Zastosowanie do inhalacji i zakraplania semifluorowanych alkanów jako nośników substancji aktywnych w strefie wewnątrzpłucnej
ES2588952T3 (es) * 2008-04-28 2016-11-07 Al.Chi.Mi.A. S.R.L. Fluoroalquiloxi alcanos, proceso para su producción y usos de los mismos
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
EP2335692A1 (en) 2009-12-04 2011-06-22 AL.CHI.MI.A. S.r.l. Silicone liquid and fluorinated liquid for sequential use in the treatment of retinal tears and/or detachments
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
BR112012023421B1 (pt) 2010-03-17 2021-09-14 Novaliq Gmbh Composição farmacêutica para tratamento de aumento de pressão intraocular
DE102010022567A1 (de) * 2010-06-02 2011-12-08 Fluoron Gmbh Zubereitung
DE202010009243U1 (de) 2010-06-02 2011-09-19 Fluoron Gmbh Zubereitung
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
CN102041142B (zh) * 2010-12-25 2013-11-20 锦州惠发天合化学有限公司 一种含氟润滑油
CN102070493B (zh) * 2011-01-04 2013-07-31 锦州惠发天合化学有限公司 一种含氟润滑油添加剂的制备方法
MX353154B (es) * 2011-01-04 2017-12-20 Novaliq Gmbh Emulsiones de aceite/agua que comprenden alcanos semifluorados.
EP2714008B1 (en) * 2011-05-25 2016-12-14 Novaliq GmbH Pharmaceutical composition for administration to nails
PL2714010T3 (pl) 2011-05-25 2017-08-31 Novaliq Gmbh Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
AU2013211645B2 (en) 2012-01-23 2017-06-15 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes
US20130272962A1 (en) 2012-04-11 2013-10-17 Fluoron Gmbh Staining agent for corneal staining
DE102012103097A1 (de) 2012-04-11 2013-10-17 Fluoron Gmbh Färbemittel zum Einfärben einer ophthalmischen Membran
CA3142049C (en) * 2012-09-12 2023-08-29 Novaliq Gmbh Semifluorinated alkane compositions
TR201812013T4 (tr) 2012-09-12 2018-09-21 Novaliq Gmbh Göz yikama bi̇leşi̇mleri̇.
CA2997744C (en) 2012-09-12 2019-12-31 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
US20160022648A1 (en) 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
EP2783703A1 (en) * 2013-03-25 2014-10-01 B. Braun Melsungen AG Semifluorocarbon compound containing contrast agent
US10066186B2 (en) * 2013-04-22 2018-09-04 Basf Se Lubricating oil compositions containing a halide seal compatibility additive and a second seal compatibility additive
CN105283529B (zh) 2013-04-22 2018-08-10 巴斯夫欧洲公司 用于改进含氟聚合物密封件相容性的润滑剂组合物的密封相容性添加剂
CA2918419C (en) 2013-07-23 2022-05-03 Novaliq Gmbh Stabilized antibody compositions
CN105705526A (zh) * 2013-11-05 2016-06-22 索尔维特殊聚合物意大利有限公司 改性的烃类
EP2944324A1 (de) * 2014-05-13 2015-11-18 LTS LOHMANN Therapie-Systeme AG Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
WO2016082644A1 (en) * 2014-11-26 2016-06-02 The University Of Hong Kong A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
DE202015101488U1 (de) * 2015-03-24 2016-06-28 Fluoron Gmbh Waschlösung
GB2542406B (en) 2015-09-18 2018-04-11 Schlumberger Holdings Determining properties of porous material by NMR
DK3356313T3 (da) * 2015-09-30 2020-07-20 Novaliq Gmbh 2-perfluorhexyloktan til oftalmisk indgivelse
WO2017055454A1 (en) 2015-09-30 2017-04-06 Novaliq Gmbh Semifluorinated compounds and their compositions
JP2019520357A (ja) 2016-06-23 2019-07-18 ノバリック ゲーエムベーハー 局所投与方法
WO2018054932A1 (en) 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
CN109906085B (zh) 2016-09-23 2024-03-08 诺瓦利克有限责任公司 含有环孢素的眼用组合物
CA3036313A1 (en) * 2016-09-28 2018-04-05 Novaliq Gmbh Compositions comprising a cannabinoid receptor binding ligand
CN106631681B (zh) * 2016-11-29 2020-07-28 上海杰视医疗科技有限公司 含氟烷烃的纯化方法
PL3612228T3 (pl) 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
WO2018202835A1 (en) 2017-05-05 2018-11-08 Novaliq Gmbh Process for the production of semifluorinated alkanes
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
WO2018228975A1 (en) 2017-06-12 2018-12-20 Novaliq Gmbh Process for the preparation of semifluorinated alkanes using grignard reagents
SG11202002640YA (en) 2017-09-27 2020-04-29 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
CA3091308A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
JP7496778B2 (ja) * 2018-03-28 2024-06-07 ノバリック ゲーエムベーハー チモロールを含む医薬組成物
WO2019206956A1 (en) 2018-04-27 2019-10-31 Novaliq Gmbh Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
AU2019345929B2 (en) 2018-09-27 2022-02-03 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
CA3112504A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
MY206642A (en) 2018-10-12 2024-12-30 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
US12397039B2 (en) 2019-02-13 2025-08-26 Novaliq Gmbh Compositions and methods for the treatment of ocular neovascularization
AU2020340561A1 (en) 2019-09-06 2022-03-31 Novaliq Gmbh Ophthalmic composition for the treatment of uveitis
AU2022217160A1 (en) 2021-02-03 2023-08-17 Ads Therapeutics Llc Topical ophthalmological compositions
WO2024208750A1 (en) 2023-04-03 2024-10-10 Dermaliq Therapeutics Gmbh Tri-azole antifungal compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997505A (en) * 1954-07-12 1961-08-22 Research Corp Fluoro-nitro olefins
DE2060041C3 (de) * 1970-12-05 1973-10-25 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von fluorierten Kohlenwasserstoffen
CA1023768A (en) * 1972-12-21 1978-01-03 Horst Jager Polyfluoroalkyl iodides, process for their manufacture, and their use
US4173654A (en) * 1977-01-03 1979-11-06 California Institute Of Technology Novel fluorohydrocarbons
JPS63281218A (ja) * 1987-05-13 1988-11-17 Hitachi Ltd 磁気記録媒体
DE3925525A1 (de) * 1989-08-02 1991-02-07 Hoechst Ag Verfahren zur herstellung von (alpha),omega-bisperfluoralkylalkanen
IT1241402B (it) * 1990-03-02 1994-01-14 Enichem Sintesi Agenti scivolanti
FR2679150A1 (fr) 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
DE4211958A1 (de) * 1992-04-01 1993-10-21 Pharmpur Gmbh Behandlungsmittel für die Augenheilkunde und seine Verwendung

Also Published As

Publication number Publication date
CA2232880A1 (en) 1997-04-10
EP0859751A1 (de) 1998-08-26
KR100457157B1 (ko) 2005-04-06
DE19536504C2 (de) 1999-09-23
KR19990063845A (ko) 1999-07-26
EP0965334A1 (de) 1999-12-22
EP0859751B1 (de) 2000-01-19
US20020198266A1 (en) 2002-12-26
KR20040064710A (ko) 2004-07-19
US6489367B1 (en) 2002-12-03
JP2004035572A (ja) 2004-02-05
EP0965334B1 (de) 2002-03-13
ATE188958T1 (de) 2000-02-15
ATE214589T1 (de) 2002-04-15
ES2174554T3 (es) 2002-11-01
JP2004083593A (ja) 2004-03-18
CA2473393C (en) 2009-10-27
CA2473393A1 (en) 1997-04-10
JP2000511157A (ja) 2000-08-29
WO1997012852A1 (de) 1997-04-10
EP0965329A1 (de) 1999-12-22
ATE214270T1 (de) 2002-03-15
US6486212B2 (en) 2002-11-26
KR100478789B1 (ko) 2005-03-24
ES2144259T3 (es) 2000-06-01
EP0859751B2 (de) 2007-07-18
CA2232880C (en) 2006-12-19
KR100497874B1 (ko) 2005-06-29
KR20040068137A (ko) 2004-07-30
CA2473394A1 (en) 1997-04-10
EP0965329B1 (de) 2002-03-20
DE59608937D1 (de) 2002-04-25
US20020128527A1 (en) 2002-09-12
DE59604257D1 (de) 2000-02-24
CA2473394C (en) 2010-02-09
US6262126B1 (en) 2001-07-17
DE19536504A1 (de) 1997-04-03
DE59608891D1 (de) 2002-04-18
ES2144259T5 (es) 2008-02-16
JP4731801B2 (ja) 2011-07-27

Similar Documents

Publication Publication Date Title
ES2174551T3 (es) Utilizacion de alcanos semifluorados como agentes dermatologicos.
YU49032B (sh) Aminopirazoli i njihova primena kao pesticida
ES2078234T3 (es) 1,3-dioxolanos sustituidos en posiciones 2 y 4, sintesis y uso de los mismos.
KR950701801A (ko) 헥사플루무론 및 관련 화합물의 흰개미살충제로서의 신규한 용도(Novel use of hexaflumuron and related compounds as termiticides)
ATE257690T1 (de) Sonnenschutzmittel
ATE206877T1 (de) Fluorierte kasein-mizellen
SE7703223L (sv) 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)kinoxalin-5(6h)-on och derivat derav
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
ES2123962T3 (es) Composicion suavizante para tejidos.
ATE63111T1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
ATE12487T1 (de) Chlorierte betaketoester, ihre herstellung und anwendung.
ES2128112T3 (es) Nuevas composiciones herbicidas.
PH21941A (en) Difluorocyclopropane derivatives,pesticidal compositions based on these compounds and method of use thereof
FI930092A0 (fi) Indanopyrrolidinkarbamater
DE68915025D1 (de) Herstellung von 3,3-Diarylacrylsäureamiden.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
TR22546A (tr) Herbisit oezellikte yeni 2-alkoksi-aminosuelfonil-benzensuelfoniluereler
ES2053686T3 (es) Nuevos di(met)acrilatos, procedimiento para su fabricacion y su empleo.
MD970084A (ro) 1-Amino-3-(bicicloheterociclil)-6-fluoralchiluracil
RO94553A (ro) Compozitie insecticida
DE3277199D1 (de) Fluorinated diamino-heptene and -heptyne derivatives
FI873483A0 (fi) Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3565265D1 (de) Benzoyl ureas
IT1218106B (it) Set di accessori,principalmente da tavola,per l'equipaggiamento portatile di escursionisti,cacciatori,pescatori e sportivi,nonche' per utilizzi vari riferiti al tempo libero

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 965329

Country of ref document: ES